Proteomic profiling of patient‐derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development

Publisher: John Wiley & Sons Inc

E-ISSN: 1471-4159|133|5|730-738

ISSN: 0022-3042

Source: JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.133, Iss.5, 2015-06, pp. : 730-738

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content